We recently published a list of UBS’ Top Quant Stocks In AI, IT, Healthcare & Other Sectors: Top 33 Stocks In All Sectors. In ...
23andMe, a popular South San Francisco-based genetic testing company, is laying off 40% of its workers after struggling with ...
They bargain. The genetic testing company 23andMe received approval this week from regulators to sell genetic reports on an individual’s risk for 10 diseases, most prominently Alzheimer’s and ...
CEO Eric Lefkofsky said the purchase of Ambry Genetics will expand Tempus’ testing portfolio and bring in a fast-growing ...
GeneDx stock rises as Q3 results beat expectations with EPS loss improvement, 44% revenue growth to $76.87M, and 77% increase ...
The genetic testing company reported a third-quarter EPS loss ... “Once again, our quarterly performance exceeded our top and bottom-line expectations. The third quarter marked our 10th ...